After semaglutide is stopped, appetite suppression fades, biological pressure to regain can return, and many patients recover a substantial portion of lost weight. The outcome is variable, not inevitable in the same degree.
Blog Grid
- Home
- Blog Grid
Tirzepatide generally produces greater average weight loss than semaglutide in obesity trials, but the correct comparison uses obesity brands and doses, not casual brand substitution.
Semaglutide is neither a miracle nor a cosmetic trick. At obesity-treatment doses it can produce clinically important weight loss and health benefits, but maintenance commonly requires continued treatment or another durable strategy.
Two people can eat apparently identical foods and show different weight trajectories because total exposure, absorption, body size, spontaneous activity, appetite compensation, sleep, genetics, microbiome, and measurement error differ.
There is no universal hidden panel for obesity. The valuable tests are those that detect complications, identify selected secondary causes, establish treatment safety, or change the level of intervention.
Overt hypothyroidism can cause weight gain, but the typical effect is often modest and partly due to salt and water retention. It does not explain every case of obesity.